IL6 and hepatocellular carcinoma: Here, activation of IL-6-dependent pathways in different cell types – especially immune cells and non-parenchymal liver cells – can also contribute to HCC development.49 The use of STAT3-cell-type-specific knockout mice bears limitations as gp130, the signaling molecule, is still expressed in the targeted cell.